Evidence map›Paper›PMID 35911677›Full record

ArticleFrontiers in immunology2022

Paraneoplastic Pemphigus Autoantibodies Against C-terminus of Desmoplakin Induced Acantholysis

Xue Wang, Rui Wang, Dingfang Bu, Leyi Wang, Yuexin Zhang, Yuan Chang, Chenyang Zhang, Xixue Chen, Xuejun Zhu, Zhi Liu and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Xue WangDepartment of Dermatology, Peking University First Hospital, Beijing, China.
Rui WangDepartment of Dermatology, Peking University First Hospital, Beijing, China.
Dingfang BuCentral Laboratory, Peking University First Hospital, Beijing, China.
Leyi WangDepartment of Dermatology, Peking University First Hospital, Beijing, China.
Yuexin ZhangDepartment of Dermatology, Peking University First Hospital, Beijing, China.
Yuan ChangDepartment of Dermatology, Peking University First Hospital, Beijing, China.
Chenyang ZhangDepartment of Dermatology, Peking University First Hospital, Beijing, China.
Xixue ChenDepartment of Dermatology, Peking University First Hospital, Beijing, China.
Xuejun ZhuDepartment of Dermatology, Peking University First Hospital, Beijing, China.
Zhi LiuDepartment of Dermatology, University of North Carolina, Chapel Hill, NC, United States.
Mingyue WangDepartment of Dermatology, Peking University First Hospital, Beijing, China.
Peking University First Hospital · CNPeking University · CNNational Clinical Research Center for Digestive Diseases · CNBeijing Children’s Hospital · CNUniversity of North Carolina at Chapel Hill · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Paraneoplastic pemphigus (PNP) is an autoimmune bullous disease associated with underlying neoplasms and characterized by antibodies against desmoglein 3 (Dsg 3) and plakins. Autoantibodies against desmoglein 3 in sera of patients with PNP have been proven to cause acantholysis

Indexed as

AcantholysisAutoantibodiesDesmoplakinsAnimalsAutoimmune DiseasesDesmoglein 3HumansImmunoglobulin GMiceParaneoplastic SyndromesPemphigusAutoantibodiesDesmoglein 3DesmoplakinsImmunoglobulin Gacantholoysisdesmogleindesmoplakinmouse modelParaneoplastic pemphigusplakin

Identifiers

PMID35911677
PMCPMC9332891
OpenAlexW4285389125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.